Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Receivables (2020 - 2023)

Historic Receivables for Immuneering (IMRX) over the last 4 years, with Q1 2023 value amounting to $1046.0.

  • Immuneering's Receivables fell 9962.59% to $1046.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $1046.0, marking a year-over-year decrease of 9962.59%. This contributed to the annual value of $12417.0 for FY2022, which is 9495.33% down from last year.
  • As of Q1 2023, Immuneering's Receivables stood at $1046.0, which was down 9962.59% from $12417.0 recorded in Q4 2022.
  • Immuneering's Receivables' 5-year high stood at $500110.0 during Q4 2020, with a 5-year trough of $1046.0 in Q1 2023.
  • Moreover, its 4-year median value for Receivables was $246040.0 (2021), whereas its average is $250479.1.
  • In the last 5 years, Immuneering's Receivables crashed by 5080.28% in 2021 and then tumbled by 9962.59% in 2023.
  • Over the past 4 years, Immuneering's Receivables (Quarter) stood at $500110.0 in 2020, then tumbled by 50.8% to $246040.0 in 2021, then crashed by 94.95% to $12417.0 in 2022, then crashed by 91.58% to $1046.0 in 2023.
  • Its Receivables was $1046.0 in Q1 2023, compared to $12417.0 in Q4 2022 and $70180.0 in Q3 2022.